Christensen, Rune Häckert
Ashina, Håkan
Ashina, Messoud
Article History
Received: 14 January 2025
Accepted: 30 July 2025
First Online: 10 November 2025
Declarations
:
: RHC has received personal fees from Teva, Pfizer, and Lundbeck, outside of the submitted work, has received honoraria from Neurotorium, and serves as section editor for the Journal of Pain Research. HA has received personal fees from AbbVie, Lundbeck, Pfizer, and Teva, outside of the submitted work. HA also serves on the Editorial Board of The Journal of Headache and Pain. MA has received personal fees from AbbVie, AstraZeneca, Eli Lilly, GlaxoSmithKline, Lundbeck, Pfizer, and Teva, outside of the submitted work; has received funding from Danish National Research Foundation, Lundbeck Foundation, Novo Nordisk Foundation, Novartis, and Lundbeck; serves as an associate editor for The Journal of Headache and Pain and associate editor for Brain; and serves on the editorial board of Neurotorium and has received honoraria.